Human Adipose-Derived Stem Cell Exosomes And Their Packaging For Use At Room Temperature
OwnerNiketa A. Patelinventor
Life of this patent
Estimating the term…
Loading patent…
OwnerNiketa A. Patelinventor
Estimating the term…
Disclosed are compositions comprising adipose stem cell (ASC) derived exosomes. Disclosed are lyophilized compositions comprising adipose stem cell (ASC) derived exosomes. Disclosed are methods of treating a wound comprising administering a composition comprising one or more adipose stem cell derived exosomes to a wound of a subject. Disclosed are methods of promoting wound healing comprising administering a composition comprising one or more adipose stem cell derived exosomes to a wound of a subject. Disclosed are methods of accelerating wound closure time comprising administering a composition comprising one or more adipose stem cell derived exosomes to a wound of a subject. Disclosed are methods of reducing oxidative stress in a human dermal fibroblasts (HDF) comprising contacting an HDF with a composition comprising one or more adipose stem cell derived exosomes. Disclosed are methods of increasing cell viability in a subject comprising administering a composition comprising one or more adipose stem cell derived exosomes to the subject.
A method of promoting wound healing comprising:
A method of treating a wound comprising:
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
-39. (canceled)
A subcutaneous-derived adipose stem cell derived exosome comprising lncRNA growth-arrest specific-5 (GAS5) and/or metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), wherein GAS5 and/or MALAT1 are overexpressed.
-50. (canceled)
Dependencies are inferred from the claim text.